Anxiety treatment for Lake Worth Beach — SSRI dosing done right, CBT that works.

RECO Integrated Psychiatry sits 22 minutes south of Lake Worth Beach in Delray Beach — close enough for weekly visits from Bryant Park, Parrot Cove, or the downtown corridor without disrupting work. Anxiety care here is diagnosis-specific and dose-specific: GAD-7, PDSS, LSAS, and Y-BOCS anchor the intake, SSRIs are titrated to the upper-range doses that anxiety disorders actually require, and therapy referrals match the disorder — ERP for OCD, interoceptive exposure for panic, in-vivo exposure for social anxiety. Benzodiazepines are used narrowly and with a defined taper, never as open-ended maintenance.

Lake Worth Beach sits 14 miles north of RECO Integrated Psychiatry’s Delray Beach office — a 22-minute drive down A1A outside of winter season, longer once seasonal traffic settles in. For adults living in Bryant Park, College Park, Mango Groves, Parrot Cove, or along the downtown Lake Worth corridor, that distance is short enough to sustain weekly medication visits and a twice-weekly therapy cadence without displacing work or family. Anxiety disorders are the single most common presenting concern in our outpatient clinic, and the treatment approach diverges meaningfully from the depression protocols they are often confused with.

The disorder distinctions that change treatment

Generalized anxiety disorder, panic disorder, social anxiety disorder, and obsessive-compulsive disorder are frequently grouped together as “anxiety” in primary care visits and in everyday conversation, yet each responds to a different therapy protocol and often to different medication dosing. RECO’s intake distinguishes them explicitly. Standardized scales anchor the diagnosis — GAD-7 for generalized anxiety, PDSS for panic disorder, LSAS for social anxiety, and Y-BOCS for obsessive-compulsive symptoms — and the DSM-5-TR primary diagnosis is named in the initial evaluation note rather than left as “anxiety NOS.”

The distinction matters because the therapy pathways diverge. OCD responds specifically to exposure and response prevention (ERP), not to generic supportive CBT. Panic disorder responds to interoceptive exposure, which deliberately provokes the physical sensations of a panic attack in a controlled setting until they lose their alarm value. Social anxiety responds to in-vivo exposure paired with cognitive restructuring around perceived scrutiny. Progressive muscle relaxation and unstructured talk therapy do not produce equivalent outcomes for any of these disorders.

Comorbid presentations are the rule rather than the exception. A client who meets criteria for both GAD and social anxiety, or for OCD with secondary panic attacks, needs a sequenced plan. RECO’s treatment plan orders the disorders by functional impact and severity, and the pharmacologic strategy is chosen to cover the primary and the comorbidity simultaneously where possible.

SSRI dosing for anxiety versus depression

Effective SSRI doses for anxiety disorders sit at the upper end of the FDA-approved range, and this is where outpatient anxiety treatment most often fails in the community. Sertraline for GAD or OCD generally requires 150-200 mg to reach therapeutic effect. Escitalopram sits at 20 mg. Paroxetine ranges from 40 to 60 mg. Fluoxetine for OCD frequently needs 60-80 mg. A client who stalled at sertraline 50 mg and was told “the SSRI didn’t work” has almost always been undertreated rather than treatment-resistant.

Initiation is the mirror image of the target dose. Anxious clients are typically started at half the usual starting dose — sertraline 12.5 mg, escitalopram 5 mg — because SSRI activation on initiation can transiently worsen anxiety, produce restlessness, and prompt discontinuation before the therapeutic window is ever reached. RECO’s default is a slow titration with an explicit dose ladder written into the after-visit summary, so the client knows exactly what the next two increases will look like and when.

The target dose is held for a full 8-12 weeks before it is labeled a partial response. OCD requires this patience in particular — Y-BOCS scores continue to fall for months after the SSRI reaches target. Premature switching is one of the most common reasons anxiety treatment fails outside of a specialty setting.

Augmentation and second-line options

Partial responders in generalized anxiety disorder are augmented with buspirone, titrated to 20-60 mg per day in divided dosing. SNRIs — venlafaxine XR or duloxetine — are a reasonable switch or add-on for GAD when SSRI response is inadequate at a maximum tolerated dose. Panic disorder partial responders typically gain more from intensifying CBT with interoceptive exposure than from pharmacologic augmentation; the evidence base favors the therapy pathway once medication is at target.

OCD partial responders are augmented with low-dose aripiprazole (2.5-10 mg) or risperidone (0.5-2 mg). The evidence for antipsychotic augmentation in OCD is stronger than the evidence for switching between SSRIs or adding an SNRI, and it is the guideline-consistent next step after 12 weeks at a maximum-tolerated SSRI dose combined with ERP.

For situational and PRN needs, propranolol (10-40 mg) covers performance anxiety without cognitive dulling. Hydroxyzine at 25-50 mg provides short-term relief with no dependence risk. Gabapentin has a role in social anxiety and in sleep-onset anxiety at doses of 300-900 mg. These agents allow RECO to cover acute anxiety without defaulting to benzodiazepines.

Benzodiazepines — when we do and don’t prescribe

Benzodiazepines have a defined but narrow role in anxiety treatment. Short-term crisis stabilization is the clearest indication — a small quantity of lorazepam or clonazepam during the SSRI initiation window, with a defined stop date, is often appropriate. A subset of panic disorder that has failed adequate trials of two SSRIs and exposure-based CBT may warrant chronic low-dose clonazepam. Neither of these is the modal case.

The reasons for restraint are specific. Benzodiazepines blunt the extinction learning that exposure-based CBT depends on; a client taking alprazolam as a rescue during exposure exercises will not accrue the same clinical gains. Chronic use carries dependence risk, tolerance, and measurable effects on working memory and processing speed. For any client with a substance use history — active or in sustained remission — RECO’s default is not to prescribe.

When benzodiazepines are prescribed here, the treatment plan documents the indication, defines a taper timeline, and names the non-benzodiazepine alternatives that will replace them: hydroxyzine, gabapentin, propranolol, or a targeted CBT referral. Open-ended maintenance without an ongoing clinical rationale is not the standard of care and is not RECO’s practice.

What to expect on the first visit

The initial evaluation runs 60-75 minutes and covers psychiatric history, medical history, current medications, and a structured symptom review anchored by GAD-7, PDSS, LSAS, and Y-BOCS as clinically indicated. PHQ-9 and ASRS are added when depression or attention symptoms are part of the presentation. Substance use is screened with an appropriate instrument, and a suicide risk assessment is part of every intake.

Clients leave the first visit with a named DSM-5-TR primary diagnosis, a written medication plan with the intended dose ladder, and a referral to the specific therapy modality that matches the diagnosis. When residential-level care is warranted — severe treatment-resistant OCD, for example — the referral is made directly rather than left for the client to navigate alone.

Follow-up cadence is typically weekly to biweekly during titration and monthly to quarterly once the client is stable on a therapeutic dose. Telepsychiatry is available for clients in Lake Worth Beach who prefer to reduce the commute once the treatment plan is established.

Insurance and admissions from Lake Worth Beach

RECO Integrated Psychiatry is in-network with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS. Verification of benefits is completed before the first appointment so the client knows the copay, deductible status, and any prior-authorization requirements before arriving. Prior authorizations for specialty agents such as clomipramine or antipsychotic augmentation are handled by the practice, not the client.

The Delray Beach office is a 22-minute drive from Lake Worth Beach via I-95 or A1A depending on time of day. Most Lake Worth Beach clients schedule mid-morning appointments to avoid the afternoon congestion on Federal Highway. New evaluations are typically scheduled within one to two weeks; established clients requesting a dose adjustment can usually be seen sooner through a brief telepsychiatry follow-up.

Serving residents of: Bryant Park, College Park, Mango Groves, Parrot Cove, downtown Lake Worth.